An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines
- 6 January 1999
- Vol. 17 (6) , 565-576
- https://doi.org/10.1016/s0264-410x(98)00235-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performanceVaccine, 1997
- Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0Immunology, 1996
- In Vitro Evaluation of the Antimicrobial Activities of Selected LozengesJournal of Pharmaceutical Sciences, 1993
- Reflections on the Efficacy of Pertussis VaccinesClinical Infectious Diseases, 1987
- Pertussis vaccine: present status and future prospectsVaccine, 1985
- Protective Activities of the Filamentous Hemagglutinin and the Lymphocytosis-Promoting Factor of Bordetella pertussis in MiceThe Journal of Infectious Diseases, 1984
- Mouse or man? Which are pertussis vaccines to protect?Epidemiology and Infection, 1976
- A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussisJournal of General Microbiology, 1970
- A comparison between the intranasal and intracerebral infection of mice with Bordetella pertussisEpidemiology and Infection, 1961
- SOME OBSERVATIONS MADE DURING EXPERIMENTS ON MICE INOCULATED WITH H. PERTUSSIS.Acta Pathologica Microbiologica Scandinavica, 1952